138 related articles for article (PubMed ID: 36690715)
1. Quantitative MRI in distinguishing bladder paraganglioma from bladder leiomyoma.
Hu X; Wang K; Sun M; Li C; Wang H; Guan J
Abdom Radiol (NY); 2023 Mar; 48(3):1051-1061. PubMed ID: 36690715
[TBL] [Abstract][Full Text] [Related]
2. Value of non-Gaussian diffusion imaging with a fractional order calculus model combined with conventional MRI for differentiating histological types of cervical cancer.
Zhang A; Hu Q; Song J; Dai Y; Wu D; Chen T
Magn Reson Imaging; 2022 Nov; 93():181-188. PubMed ID: 35988835
[TBL] [Abstract][Full Text] [Related]
3. Bladder paraganglioma in adults: MR appearance in four patients.
Wang H; Ye H; Guo A; Wei Z; Zhang X; Zhong Y; Fan Z; Wang Y; Wang D
Eur J Radiol; 2011 Dec; 80(3):e217-20. PubMed ID: 20950973
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
[TBL] [Abstract][Full Text] [Related]
5. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
Wang Y; Shen Y; Hu X; Li Z; Feng C; Hu D; Kamel IR
AJR Am J Roentgenol; 2020 Feb; 214(2):383-389. PubMed ID: 31670586
[No Abstract] [Full Text] [Related]
6. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
Zhang X; Wang Y; Zhang J; Xu X; Zhang L; Zhang M; Xie L; Shou J; Chen Y
Abdom Radiol (NY); 2022 Jun; 47(6):2148-2157. PubMed ID: 35306580
[TBL] [Abstract][Full Text] [Related]
7. Utility of intravoxel incoherent motion MRI derived parameters for prediction of aggressiveness in urothelial bladder carcinoma.
Zhang M; Chen Y; Cong X; Zhao X
J Magn Reson Imaging; 2018 Dec; 48(6):1648-1656. PubMed ID: 29740903
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.
Malla SR; Bhalla AS; Manchanda S; Kandasamy D; Kumar R; Agarwal S; Shamim SA; Kakkar A
Head Neck; 2021 Sep; 43(9):2611-2622. PubMed ID: 33938085
[TBL] [Abstract][Full Text] [Related]
9. Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer.
Li S; Liang P; Wang Y; Feng C; Shen Y; Hu X; Hu D; Meng X; Li Z
Abdom Radiol (NY); 2021 Sep; 46(9):4301-4310. PubMed ID: 33909091
[TBL] [Abstract][Full Text] [Related]
10. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
Wang F; Wu LM; Hua XL; Zhao ZZ; Chen XX; Xu JR
J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
[TBL] [Abstract][Full Text] [Related]
11. Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients.
Liang J; Li H; Gao L; Yin L; Yin L; Zhang J
Urol J; 2016 Apr; 13(2):2605-11. PubMed ID: 27085560
[TBL] [Abstract][Full Text] [Related]
12. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings.
Suo ST; Chen XX; Fan Y; Wu LM; Yao QY; Cao MQ; Liu Q; Xu JR
Acad Radiol; 2014 Aug; 21(8):1027-34. PubMed ID: 24833566
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer.
Ahmed SA; Taher MGA; Ali WA; Ebrahem MAES
Abdom Radiol (NY); 2021 Jun; 46(6):2712-2721. PubMed ID: 33547919
[TBL] [Abstract][Full Text] [Related]
15. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
16. Investigation of Synthetic Magnetic Resonance Imaging Applied in the Evaluation of the Tumor Grade of Bladder Cancer.
Cai Q; Wen Z; Huang Y; Li M; Ouyang L; Ling J; Qian L; Guo Y; Wang H
J Magn Reson Imaging; 2021 Dec; 54(6):1989-1997. PubMed ID: 34080268
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
Meng X; Hu H; Wang Y; Feng C; Hu D; Liu Z; Kamel IR; Li Z
J Magn Reson Imaging; 2022 Aug; 56(2):391-398. PubMed ID: 35049074
[TBL] [Abstract][Full Text] [Related]
18. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI and
Yoo J; Kim SH; Han JK
Eur Radiol; 2020 Mar; 30(3):1634-1643. PubMed ID: 31781931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
